Monte Rosa Therapeutics, Inc.

GLUE · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$208,343$69,429$78,530$224,254
Short-Term Investments$182,915$221,165$247,544$147,895
Receivables$4,965$2,370$1,408$173
Inventory$0$0$0$0
Other Curr. Assets$5,594$6,501$4,798$5,118
Total Curr. Assets$401,817$299,465$332,280$377,440
Property Plant & Equip (Net)$52,663$54,726$55,599$56,314
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$4,950$0$0
Tax Assets$0$0$0$0
Other NC Assets$5,361$445$5,320$4,978
Total NC Assets$58,024$60,121$60,919$61,292
Other Assets$0$0$0$0
Total Assets$459,841$359,586$393,199$438,732
Liabilities
Payables$14,509$5,581$6,489$17,215
Short-Term Debt$4,241$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$24,791$18,410$32,575$117,232
Other Curr. Liab.$17,902$8,637$8,262$11,574
Total Curr. Liab.$61,443$41,852$59,216$156,946
LT Debt$35,927$0$0$0
Deferred Rev, NC$0$8,059$16,863$16,147
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$116,634$4,558$3,961$3,702
Total NC Liab.$152,561$49,654$58,823$58,850
Other Liabilities$0$0$0$0
Cap. Leases$40,168$41,131$41,864$42,715
Total Liabilities$214,004$91,506$118,039$215,796
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings-$431,079-$403,998-$391,703-$438,588
AOCI-$3,247-$3,373-$3,329-$3,356
Other Equity$680,157$0$0$0
Total Equity$245,837$268,080$275,160$222,936
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$459,841$359,586$393,199$438,732
Net Debt-$168,175-$69,429-$78,530-$224,254